Prospective evaluation of serum alkaline phosphatase variability and prognostic utility in primary sclerosing cholangitis using controlled clinical trial data

被引：2

作者：

Trivedi, Palak ^{[1
,2
,3
,4
,5
]}

Muir, Andrew ^{[6
]}

Levy, Cynthia ^{[7
]}

Bowlus, Christopher ^{[8
]}

Manns, Michael P. ^{[9
]}

Lu, Xiaomin ^{[10
]}

Crans, Gerald ^{[10
]}

Subramanian, Mani ^{[10
]}

Myers, Robert ^{[10
]}

Goodman, Zachary ^{[11
]}

Chalasani, Naga ^{[12
]}

Vierling, John M. ^{[13
]}

Guha, Neil ^{[14
]}

Hirschfield, Gideon ^{[15
]}

机构：

[1] NIHR Birmingham BRC, Birmingham, W Midlands, England

[2] Ctr Liver Res, Birmingham, W Midlands, England

[3] Inst Immunol & Immunotherapy, Birmingham, W Midlands, England

[4] Inst Appl Hlth Res, Birmingham, W Midlands, England

[5] Univ Hosp Birmingham Queen Elizabeth, Liver Unit, Birmingham, W Midlands, England

[6] Duke Clin Res Inst, Durham, NC USA

[7] Univ Miami, Miami, FL USA

[8] Univ Calif Davis, Davis, CA 95616 USA

[9] Hannover Med Sch, Hannover, Germany

[10] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[11] Inova Fairfax Hosp, Annandale, VA USA

[12] Indiana Univ Sch Med, Indianapolis, IN 46202 USA

[13] Baylor Coll Med, Houston, TX 77030 USA

[14] Univ Nottingham, NIHR Nottingham BRC, Nottingham, England

[15] Univ Toronto, Toronto Ctr Liver Dis, Univ Hlth Network, Toronto, ON, Canada

来源：

JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期

关键词：

D O I：

10.1016/S0618-8278(19)30022-2

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

PS-016

引用

页码：E12 / E13

页数：2

共 50 条

[41] A Triple Blinded, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis: a Pilot Study
Rahimpour, Shahab
Nasiri-Toosi, Mohsen
Khalili, Hossein
Daryani, Nasser Ebrahimi
Taromlou, Mohammad Kazem Nouri
Azizi, Zahra
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2016, 25 (04) : 457 - 464
[42] CLINICAL UTILITY OF PET/CT IN THE EVALUATION OF HEAD AND NECK SQUAMOUS CELL CARCINOMA WITH AN UNKNOWN PRIMARY: A PROSPECTIVE CLINICAL TRIAL
Rudmik, Luke
Lau, Harold Y.
Matthews, T. Wayne
Bosch, J. Douglas
Kloiber, Reinhard
Molnar, Christine P.
Dort, Joseph C.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (07): : 935 - 940
[43] Defining Disease Severity and Measuring Progression in Primary Sclerosing Cholangitis (PSC): A Comparison of the Disease Severity Index (DSI) from the Hepquant Shunt Test with Serum Alkaline Phosphatase (Alk Phos)
Helmke, Steve M.
Everson, Gregory T.
HEPATOLOGY, 2018, 68 : 1087A - 1087A
[44] EFFECT OF OBETICHOLIC ACID ON PROGNOSTIC THRESHOLDS OF GAMMA-GLUTAMYL TRANSFERASE AND ALKALINE PHOSPHATASE LEVELS: SUB-ANALYSIS OF THE PHASE 3 POISE TRIAL IN PRIMARY BILIARY CHOLANGITIS
Bonder, Alan
Wheeler, Darren
Nair, Radhika
Ness, Erik
Malecha, Elizabeth S.
Gish, Robert G.
HEPATOLOGY, 2023, 78 : S2047 - S2048
[45] Serum bile acids significantly associate with the fibrogenesis biomarker Pro-C3: analysis of a randomized, placebo-controlled trial of NGM282 in patients with primary sclerosing cholangitis
Hirschfield, Gideon
Ling, Lei
Jaros, Mark
Kim, Kathline H.
Baxter, Bryan
Depaoli, Alex
Mayo, Marlyn J.
Beuers, Ulrich
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E395 - E396
[46] Unmet Need of Patients with Primary Biliary Cholangitis (PBC) Based on Alkaline Phosphatase (ALP) Threshold Using Large Database with Electronic Medical Records (EMRs) and Claims Data: A Cross-sectional Analysis
Younossi, Zobair M.
Epstein, Robert S.
Strauss, Marcie
Dixit, Shailja
HEPATOLOGY, 2017, 66 : 154A - 155A
[47] Typhoid conjugate vaccine effectiveness in Malawi: evaluation of a test-negative design using randomised, controlled clinical trial data
Liang, Yuanyuan
Driscoll, Amanda J.
Patel, Priyanka D.
Datta, Shrimati
Voysey, Merryn
French, Neil
Jamka, Leslie P.
Henrion, Marc Y. R.
Ndeketa, Latif
Laurens, Matthew B.
Heyderman, Robert S.
Gordon, Melita A.
Neuzil, Kathleen M.
LANCET GLOBAL HEALTH, 2023, 11 (01): : 136 - 144
[48] Clinical and histological evaluation of a single high energy microwave treatment for primary axillary hyperhidrosis in Asians: A prospective, randomized, controlled, split-area comparative trial
Kaminaka, Chikako
Mikita, Naoya
Inaba, Yutaka
Kunimoto, Kayo
Okuhira, Hisako
Jinnin, Masatoshi
Kao, Bunsho
Tanino, Ryuzaburo
Tanioka, Kensuke
Shimokawa, Toshio
Yamamoto, Yuki
LASERS IN SURGERY AND MEDICINE, 2019, 51 (07) : 592 - 599
[49] Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial
Pollard, Rodney P. E.
Abdulahad, Wayel H.
Vissink, Arjan
Hamza, Nishath
Burgerhof, Johannes G. M.
Meijer, Jiska M.
Visser, Annie
Huitema, Minke G.
Spijkervet, Fred K. L.
Kallenberg, Cees G. M.
Bootsma, Hendrika
Kroese, Frans G. M.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (01) : 146 - 148
[50] Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial
Spijkervet, F. K. L.
Pollard, R. P. E.
Abdulahad, W. H.
Huitema, M. G.
Visser, A.
Meijer, J. M.
Burgerhof, J. G. M.
Kallenberg, C. G. M.
Vissink, A.
Kroese, F. G. M.
Bootsma, H.
ORAL DISEASES, 2012, 18 : 13 - 13

← 1 2 3 4 5 →